Lebwohl, M.; Strober, B.; Schrader, A.; Li, A.; Eckmann, T.; Zhu, B.; Malatestinic, W.; Birt, J.; Feely, M.; Blauvelt, A. 6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. J of Skin 2023, 7, s232.